Page All:
Page 1
MediSapiens to Provide Bayer HealthCare Pharmaceuticals With a New Cloud Computing Application to Analyze and Visualize Multi-Dimensional Genomics Data
HELSINKI, November 5, 2012 /PRNewswire/ --
MediSapiens Ltd, a Finnish company developing web-based data applications for the
pharmaceutical industry, today announced that Bayer HealthCare Pharmaceuticals has
purchased a new software solution developed by MediSapiens. The software, called
OncoGenomics Explorer [http://www.medisapiens.com ] will provide Bayer HealthCare
Pharmaceuticals with a centralized access to unified global genomics data for utilization
across the entire research organization from target discovery to drug repositioning.
(Logo:
http://photos.prnewswire.com/prnh/20121105/573244 )
"Big Data, a term invented for a collection of data sets so large and complex that it
becomes difficult to process using on-hand database management tools is quickly becoming
increasingly important in pharmaceutical research. Until now, the lack of software tools
that can be adapted to various research environments has limited the full-scale use of
this enormous reservoir of available data. OncoGenomics Explorer is our answer to this
demand," says Tommi Pisto, CEO of MediSapiens Ltd.
About MediSapiens
MediSapiens is a bioinformatics company developing inspiring web applications for
genomics researchers, pharmaceutical industry and personalized medicine. MediSapiens has
unique know-how in developing software solutions for integration of both molecular and
clinical data from preclinical models to interpreting comprehensive molecular profiles of
individual cancer patients in clinical settings. Based on the world's largest unified gene
expression database, MediSapiens platform extends into highly tailored solutions to meet
the exact needs of various demanding research environments.
For more information visit http://www.medisapiens.com or email
contact@medisapiens.com
Media Contact
Tommi Pisto, CEO, Co-Founder
MediSapiens Ltd
Tukholmankatu 8 A
00290 Helsinki
Finland
Phone: +358-50-3631848 [skype:+358503631848 ]
tommi.pisto@medisapiens.com
Photo:
http://photos.prnewswire.com/prnh/20121105/573244
Photo:http://photos.prnewswire.com/prnh/20121105/573244
http://photoarchive.ap.org/
MediSapiens
MediSapiens to Provide Bayer HealthCare Pharmaceuticals With a New Cloud Computing Application to Analyze and Visualize Multi-Dimensional Genomics Data
HELSINKI, November 5, 2012 /PRNewswire/ --
MediSapiens Ltd, a Finnish company developing web-based data applications for the
pharmaceutical industry, today announced that Bayer HealthCare Pharmaceuticals has
purchased a new software solution developed by MediSapiens. The software, called
OncoGenomics Explorer [http://www.medisapiens.com ] will provide Bayer HealthCare
Pharmaceuticals with a centralized access to unified global genomics data for utilization
across the entire research organization from target discovery to drug repositioning.
(Logo:
http://photos.prnewswire.com/prnh/20121105/573244 )
"Big Data, a term invented for a collection of data sets so large and complex that it
becomes difficult to process using on-hand database management tools is quickly becoming
increasingly important in pharmaceutical research. Until now, the lack of software tools
that can be adapted to various research environments has limited the full-scale use of
this enormous reservoir of available data. OncoGenomics Explorer is our answer to this
demand," says Tommi Pisto, CEO of MediSapiens Ltd.
About MediSapiens
MediSapiens is a bioinformatics company developing inspiring web applications for
genomics researchers, pharmaceutical industry and personalized medicine. MediSapiens has
unique know-how in developing software solutions for integration of both molecular and
clinical data from preclinical models to interpreting comprehensive molecular profiles of
individual cancer patients in clinical settings. Based on the world's largest unified gene
expression database, MediSapiens platform extends into highly tailored solutions to meet
the exact needs of various demanding research environments.
For more information visit http://www.medisapiens.com or email
contact@medisapiens.com
Media Contact
Tommi Pisto, CEO, Co-Founder
MediSapiens Ltd
Tukholmankatu 8 A
00290 Helsinki
Finland
Phone: +358-50-3631848 [skype:+358503631848 ]
tommi.pisto@medisapiens.com
Photo:
http://photos.prnewswire.com/prnh/20121105/573244
Photo:http://photos.prnewswire.com/prnh/20121105/573244
http://photoarchive.ap.org/
MediSapiens